ARTICLE | Clinical News
Rasilez aliskiren: Phase III start
June 23, 2008 7:00 AM UTC
Novartis AG (NYSE:NVS; SWX:NOVN), Basel, Switzerland Product: Rasilez aliskiren ( Tekturna, SPP100) Business: Cardiovascular Molecular target: Renin Description: Renin inhibitor Indication: Treat c...